Become an A2Dominion Board Member

30 July 2026
Do you want to help shape the future of A2Dominion and make a difference for residents?

We're looking for two new Non-Executive Directors to join our Group Board.
A group of people in business clothing around a table

This is an opportunity to influence important decisions about our homes, services and communities while helping us deliver our vision of providing homes people love to live in.  

We're keen to hear from people from a wide range of backgrounds, including those with lived experience of social housing.  

You don't need previous board experience, but you'll need good judgement, an interest in making a positive impact and the confidence to share your views and challenge constructively. 

The roles are paid, with an annual remuneration of £14,448, and require an average commitment of around 2.5 days per month. Meetings are held in person in Ealing, London. 

We're recruiting for: 

  • one person with senior leadership experience in HR, people and culture to chair our Governance, People & Remuneration Committee; and 

  • one person to bring technology and digital expertise to the Board and its Audit & Risk Committee. 

Alan Collett, Chair of A2Dominion’s Group Board, said: “We are keen to widen the range of backgrounds and perspectives around our Board table. We warmly encourage applications from individuals with the broadest range of backgrounds and perspectives, and especially encourage people with lived experience of social housing to come forward for a discussion.” 

Applications need to be made via New Steet Consulting Group through its website -  

2 x Non-Executives, A2Dominion | NSCG

You can also view the candidate pack here:  https://nscg.maglr.com/a2d/candidate-pack 

For an initial informal discussion please Hannah Scarisbrick at New Street Consulting Group by emailing [email protected]  

Applications will close at 9am on 10 August 2026. 

Interviews will take place in person at A2Dominion’s Ealing office in September (exact dates to be confirmed).